AC
Asio Capital’s Regeneron Pharmaceuticals REGN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-3,995
| Closed | -$2.53M | – | 116 |
|
2025
Q1 | $2.53M | Buy |
3,995
+477
| +14% | +$303K | 0.49% | 61 |
|
2024
Q4 | $2.51M | Buy |
3,518
+724
| +26% | +$516K | 0.47% | 69 |
|
2024
Q3 | $2.94M | Buy |
2,794
+104
| +4% | +$109K | 0.56% | 64 |
|
2024
Q2 | $2.83M | Buy |
2,690
+145
| +6% | +$152K | 0.58% | 61 |
|
2024
Q1 | $2.45M | Buy |
2,545
+43
| +2% | +$41.4K | 0.52% | 68 |
|
2023
Q4 | $2.2M | Buy |
2,502
+34
| +1% | +$29.9K | 0.51% | 71 |
|
2023
Q3 | $2.03M | Buy |
2,468
+198
| +9% | +$163K | 0.54% | 66 |
|
2023
Q2 | $1.63M | Buy |
2,270
+27
| +1% | +$19.4K | 0.4% | 80 |
|
2023
Q1 | $1.84M | Buy |
2,243
+86
| +4% | +$70.7K | 0.48% | 74 |
|
2022
Q4 | $1.56M | Sell |
2,157
-2,204
| -51% | -$1.59M | 0.45% | 77 |
|
2022
Q3 | $3M | Buy |
4,361
+394
| +10% | +$271K | 0.95% | 47 |
|
2022
Q2 | $2.35M | Buy |
3,967
+92
| +2% | +$54.4K | 0.74% | 60 |
|
2022
Q1 | $2.71M | Buy |
3,875
+469
| +14% | +$328K | 0.76% | 56 |
|
2021
Q4 | $2.15M | Buy |
3,406
+376
| +12% | +$237K | 0.67% | 67 |
|
2021
Q3 | $1.83M | Buy |
3,030
+658
| +28% | +$398K | 0.63% | 66 |
|
2021
Q2 | $1.33M | Buy |
2,372
+602
| +34% | +$336K | 0.47% | 72 |
|
2021
Q1 | $837K | Buy |
+1,770
| New | +$837K | 0.35% | 72 |
|